Blood CancersBreast CancerCancer Genetics and Prevention Cutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
In light of actress Angelina Jolie's announcement that she had a preventive double mastectomy after testing positive for the BRCA1 gene mutation, Dr. Judy Garber discusses breast cancer risk, family history, testing for BRCA mutations, and preventive options for breast and ovarian cancer.
Dana-Farber investigators led a phase 1 trial in which a new oral targeted drug, idelalisib, (GS-1101), showed the potential to stave off the need for additional treatments for relapsed or treatment-resistant CLL.
Dr. Frei led Dana-Farber from 1973-1980. During the 1950s and 1960s, Dr. Frei became known as the "father of combination chemotherapy" for demonstrating that treatment with multiple chemotherapy agents could produce lasting remissions in children with acute lymphoblastic leukemia.
A type of low-grade but sometimes lethal brain tumor in children has been found to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors.
Almost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.
Dr. Huma Rana joins other Boston medical experts to say the latest science backs up Angelina Jolie's choice to undergo a preventive double mastectomy.
Dr. Sharon Bober said there are women who undergo a preventive double mastectomy, but never tell because they may not get the same support as women diagnosed with breast cancer.
Dr. Judy Garber spoke about Angelina Jolie's decision to undergo a preventive double mastectomy.
Dr. Richard Stone discusses how mutations in a gene involved in the production of white blood cells may improve the diagnosis — and perhaps treatment — of two rare blood cancers.
Calm Abiding with the Muse: Guided Meditation and Prompted Freewriting(3)
1:30 PM - 3:00 PM
Blum Resource Center Yawkey One
Kathleen Willis Morton, author, teacher, and chaplain, joins us for this hands-on workshop that include meditation and writing. All levels welcome; no writing experience required! To register or for more information, contact Sarah Singer @ 617-632-3751 or email@example.com
Facing Forward after Breast Cancer So. Weymouth
6:00 PM - 7:30 PM
101 Columbian Street South Weymouth MA 02190
A support group for women who have recently completed or will soon
complete treatment for breast cancer. Call Alison Feely, LICSW for more
information at 781-624-4790
Support for the Caregiver’s Journey: Sharing Your Journey Through Story(2)
12:00 PM - 1:30 PM
When someone receives a life-challenging diagnosis, they set out on a journey they did not choose and would rather not take. When a loved one chooses to walk that path by their side as a caregiver, they too are thrust into life-changing experiences that one may never have anticipated. In this workshop, we will uncover the common paths that caregivers walk, and leave with new tools and insights to sustain us through this time in our lives.Lani Peterson is a psychologist, life coach and professional storyteller who specializes in the use of story for personal growth, connection and change. Whether telling a story or listening to the story of another, Lani guides participants to mindfully explore their own journey.,. leading to insight, understanding and acceptance.
Patient referral information, clinical resources and more.
For adults:877-442-3324 (877-442-DFCI)For children:888-733-4662 (888-PEDI-ONC)Or complete the online form.
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
More ways to helpGiving Catalog
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free:
(866) 408-DFCI (3324)